WO2017095111A1 - Composition pour édition génomique, contenant cas9 dérivé de f. novicida - Google Patents

Composition pour édition génomique, contenant cas9 dérivé de f. novicida Download PDF

Info

Publication number
WO2017095111A1
WO2017095111A1 PCT/KR2016/013887 KR2016013887W WO2017095111A1 WO 2017095111 A1 WO2017095111 A1 WO 2017095111A1 KR 2016013887 W KR2016013887 W KR 2016013887W WO 2017095111 A1 WO2017095111 A1 WO 2017095111A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
ribonucleic acid
cell
nucleic acid
acid protein
Prior art date
Application number
PCT/KR2016/013887
Other languages
English (en)
Korean (ko)
Inventor
김진수
이승환
김광은
Original Assignee
기초과학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 기초과학연구원 filed Critical 기초과학연구원
Publication of WO2017095111A1 publication Critical patent/WO2017095111A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing

Definitions

  • a genome correction technique using Cas9 protein from F. novicida More specifically,. Ribonucleic acid protein comprising the Cas9 protein and guide RNA derived, genome calibration composition comprising the ribonucleic acid protein, genome calibration method using the ribonucleic acid protein, method for preparing a transformant by introducing the ribonucleic acid protein , And a transformant produced by the above production method is provided.
  • 5b is a result of analysis of the same experimental and control groups used in the T7E1 assay by AAVS 1 targeted deep sequencing, quantifying the degree of mutation (Insertion and deletion%), and histogram quantification of the target DNA cut by SpCas9 and FnCas9. Representative patterns were shown (arrows indicate cleavage sites cut by each protein).
  • FnCas9-guideR A complex It is delivered intracellularly with FnCas9-guideR A complex. 5, -conjugation ends are generated by FnCas9 in the target region of the plasmid and the intracellular genome, and by using this, GFP, which is an external gene, is efficiently combined and inserted into the intracellular genome. As the target protein is expressed only in the presence of the internal promoter, the GFP fluorescence signal can be confirmed. Cut by FnCas9
  • 8b shows the results of a deep-sequencing comparison of the knock-in efficiency of FnCas9 and SpCas9 into specific genes (CCR5 (TS1)) in ⁇ 93 cells.
  • FnCas9 protein The production of FnCas9 protein was confirmed (FIG. 1).
  • Figure 2c shows a logo scheme by deep-sequencing analysis.
  • FIG. 7 The process is shown schematically in FIG. As shown in FIG. 7, there is no promoter and a plasmid containing the GFP gene is prepared and delivered to the cell together with the FnCas9-guideRNA complex. 5'-conjugation ends are generated by FnCas9 in the target region of the plasmid and the intracellular genome, and by using this, GFP, which is an external gene, is efficiently bound in a cell similar to the NHEJ method.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Au moyen d'un procédé de la présente invention, les limitations d'un système CRISPR-Cas9 conventionnel utilisant une protéine Cas9 de S. pyogene peuvent être résolues et, par conséquent, le procédé peut être efficacement utilisé dans une technique d'édition génomique.
PCT/KR2016/013887 2015-11-30 2016-11-29 Composition pour édition génomique, contenant cas9 dérivé de f. novicida WO2017095111A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0168794 2015-11-30
KR20150168794 2015-11-30

Publications (1)

Publication Number Publication Date
WO2017095111A1 true WO2017095111A1 (fr) 2017-06-08

Family

ID=58797361

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/013887 WO2017095111A1 (fr) 2015-11-30 2016-11-29 Composition pour édition génomique, contenant cas9 dérivé de f. novicida

Country Status (2)

Country Link
KR (1) KR101906491B1 (fr)
WO (1) WO2017095111A1 (fr)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018054911A1 (fr) 2016-09-23 2018-03-29 Bayer Cropscience Nv Optimisation ciblée du génome dans des plantes
US9999671B2 (en) 2013-09-06 2018-06-19 President And Fellows Of Harvard College Delivery of negatively charged proteins using cationic lipids
US10113163B2 (en) 2016-08-03 2018-10-30 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
US10167457B2 (en) 2015-10-23 2019-01-01 President And Fellows Of Harvard College Nucleobase editors and uses thereof
US10323236B2 (en) 2011-07-22 2019-06-18 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US10465176B2 (en) 2013-12-12 2019-11-05 President And Fellows Of Harvard College Cas variants for gene editing
US10508298B2 (en) 2013-08-09 2019-12-17 President And Fellows Of Harvard College Methods for identifying a target site of a CAS9 nuclease
US10597679B2 (en) 2013-09-06 2020-03-24 President And Fellows Of Harvard College Switchable Cas9 nucleases and uses thereof
US10704062B2 (en) 2014-07-30 2020-07-07 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
US10858639B2 (en) 2013-09-06 2020-12-08 President And Fellows Of Harvard College CAS9 variants and uses thereof
US11046948B2 (en) 2013-08-22 2021-06-29 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US11268082B2 (en) 2017-03-23 2022-03-08 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable DNA binding proteins
US11306324B2 (en) 2016-10-14 2022-04-19 President And Fellows Of Harvard College AAV delivery of nucleobase editors
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
US11447770B1 (en) 2019-03-19 2022-09-20 The Broad Institute, Inc. Methods and compositions for prime editing nucleotide sequences
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
US11732274B2 (en) 2017-07-28 2023-08-22 President And Fellows Of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
US11795443B2 (en) 2017-10-16 2023-10-24 The Broad Institute, Inc. Uses of adenosine base editors
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
US11912985B2 (en) 2020-05-08 2024-02-27 The Broad Institute, Inc. Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019103442A2 (fr) * 2017-11-21 2019-05-31 한국생명공학연구원 Composition d'édition génomique utilisant un système crispr/cpf1 et son utilisation
WO2021111466A1 (fr) * 2019-12-02 2021-06-10 Council Of Scientific & Industrial Research Procédé et kit de détection d'un polynucléotide
KR102573947B1 (ko) * 2021-08-09 2023-09-01 경상국립대학교산학협력단 콩 유전자교정 효율 증대를 위한 유전자교정 시스템 및 이의 용도
KR102574819B1 (ko) * 2021-08-09 2023-09-04 경상국립대학교산학협력단 P34와 이의 상동체 동시 타겟 유전자교정 시스템 및 이의 용도
KR102573948B1 (ko) * 2021-08-09 2023-09-01 경상국립대학교산학협력단 Mips1과 이의 상동체 동시 타겟 유전자교정 시스템 및 이의 용도
KR102584891B1 (ko) * 2021-08-09 2023-10-04 경상국립대학교산학협력단 GmIPK1 유전자교정 시스템 및 이의 용도
KR102573952B1 (ko) * 2021-08-09 2023-09-01 경상국립대학교산학협력단 E2와 이의 상동체 동시 타겟 유전자교정 시스템 및 이의 용도

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014113493A1 (fr) * 2013-01-16 2014-07-24 Emory University Complexes d'acide nucléique cas9 et leurs utilisations
US20140356959A1 (en) * 2013-06-04 2014-12-04 President And Fellows Of Harvard College RNA-Guided Transcriptional Regulation
JP2015510778A (ja) * 2012-03-20 2015-04-13 ヴィリニュス・ユニヴァーシティー Ｃａｓ９−ｃｒＲＮＡ複合体によるＲＮＡ指向性ＤＮＡ切断

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016537028A (ja) 2013-11-18 2016-12-01 クリスパー セラピューティクス アーゲー Ｃｒｉｓｐｒ−ｃａｓシステムの材料及び方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015510778A (ja) * 2012-03-20 2015-04-13 ヴィリニュス・ユニヴァーシティー Ｃａｓ９−ｃｒＲＮＡ複合体によるＲＮＡ指向性ＤＮＡ切断
WO2014113493A1 (fr) * 2013-01-16 2014-07-24 Emory University Complexes d'acide nucléique cas9 et leurs utilisations
US20140356959A1 (en) * 2013-06-04 2014-12-04 President And Fellows Of Harvard College RNA-Guided Transcriptional Regulation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KARVELIS -§: "crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus", RNA BIOLOGY, vol. 10, no. 5, 2013, pages 841 - 851, XP055539891, DOI: doi:10.4161/rna.24203 *
PRICE: "Cas9-mediated targeting of viral RNA in eukaryotic cells", PNAS, vol. 112, no. 19, 12 May 2015 (2015-05-12), pages 6164 - 6169, XP055335247, DOI: doi:10.1073/pnas.1422340112 *

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12006520B2 (en) 2011-07-22 2024-06-11 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US10323236B2 (en) 2011-07-22 2019-06-18 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US10508298B2 (en) 2013-08-09 2019-12-17 President And Fellows Of Harvard College Methods for identifying a target site of a CAS9 nuclease
US10954548B2 (en) 2013-08-09 2021-03-23 President And Fellows Of Harvard College Nuclease profiling system
US11920181B2 (en) 2013-08-09 2024-03-05 President And Fellows Of Harvard College Nuclease profiling system
US11046948B2 (en) 2013-08-22 2021-06-29 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US10682410B2 (en) 2013-09-06 2020-06-16 President And Fellows Of Harvard College Delivery system for functional nucleases
US10597679B2 (en) 2013-09-06 2020-03-24 President And Fellows Of Harvard College Switchable Cas9 nucleases and uses thereof
US11299755B2 (en) 2013-09-06 2022-04-12 President And Fellows Of Harvard College Switchable CAS9 nucleases and uses thereof
US10858639B2 (en) 2013-09-06 2020-12-08 President And Fellows Of Harvard College CAS9 variants and uses thereof
US10912833B2 (en) 2013-09-06 2021-02-09 President And Fellows Of Harvard College Delivery of negatively charged proteins using cationic lipids
US9999671B2 (en) 2013-09-06 2018-06-19 President And Fellows Of Harvard College Delivery of negatively charged proteins using cationic lipids
US10465176B2 (en) 2013-12-12 2019-11-05 President And Fellows Of Harvard College Cas variants for gene editing
US11053481B2 (en) 2013-12-12 2021-07-06 President And Fellows Of Harvard College Fusions of Cas9 domains and nucleic acid-editing domains
US11124782B2 (en) 2013-12-12 2021-09-21 President And Fellows Of Harvard College Cas variants for gene editing
US10704062B2 (en) 2014-07-30 2020-07-07 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
US11578343B2 (en) 2014-07-30 2023-02-14 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
US10167457B2 (en) 2015-10-23 2019-01-01 President And Fellows Of Harvard College Nucleobase editors and uses thereof
US11214780B2 (en) 2015-10-23 2022-01-04 President And Fellows Of Harvard College Nucleobase editors and uses thereof
US11702651B2 (en) 2016-08-03 2023-07-18 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
US10113163B2 (en) 2016-08-03 2018-10-30 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
US11999947B2 (en) 2016-08-03 2024-06-04 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
US10947530B2 (en) 2016-08-03 2021-03-16 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
WO2018054911A1 (fr) 2016-09-23 2018-03-29 Bayer Cropscience Nv Optimisation ciblée du génome dans des plantes
US11306324B2 (en) 2016-10-14 2022-04-19 President And Fellows Of Harvard College AAV delivery of nucleobase editors
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
US11820969B2 (en) 2016-12-23 2023-11-21 President And Fellows Of Harvard College Editing of CCR2 receptor gene to protect against HIV infection
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
US11268082B2 (en) 2017-03-23 2022-03-08 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable DNA binding proteins
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
US11732274B2 (en) 2017-07-28 2023-08-22 President And Fellows Of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
US11932884B2 (en) 2017-08-30 2024-03-19 President And Fellows Of Harvard College High efficiency base editors comprising Gam
US11795443B2 (en) 2017-10-16 2023-10-24 The Broad Institute, Inc. Uses of adenosine base editors
US11795452B2 (en) 2019-03-19 2023-10-24 The Broad Institute, Inc. Methods and compositions for prime editing nucleotide sequences
US11447770B1 (en) 2019-03-19 2022-09-20 The Broad Institute, Inc. Methods and compositions for prime editing nucleotide sequences
US11643652B2 (en) 2019-03-19 2023-05-09 The Broad Institute, Inc. Methods and compositions for prime editing nucleotide sequences
US11912985B2 (en) 2020-05-08 2024-02-27 The Broad Institute, Inc. Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence

Also Published As

Publication number Publication date
KR101906491B1 (ko) 2018-12-05
KR20170063399A (ko) 2017-06-08

Similar Documents

Publication Publication Date Title
WO2017095111A1 (fr) Composition pour édition génomique, contenant cas9 dérivé de f. novicida
AU2017268502B2 (en) Compositions and methods for modifying a predetermined target nucleic acid sequence
JP7075170B2 (ja) 延長された単一ガイドｒｎａ及びその用途
AU2016316845B2 (en) Engineered CRISPR-Cas9 nucleases
JP6835726B2 (ja) Ｃｒｉｓｐｒハイブリッドｄｎａ／ｒｎａポリヌクレオチドおよび使用方法
RU2699523C2 (ru) Рнк-направляемая инженерия генома человека
JP2023168355A (ja) 改良された相同組換えおよびその組成物のための方法
CN106922154A (zh) 使用空肠弯曲杆菌crispr/cas***衍生的rna引导的工程化核酸酶的基因编辑
JP2023517041A (ja) クラスｉｉのｖ型ｃｒｉｓｐｒ系
EP3612630B1 (fr) Modification d'adn spécifique de site à l'aide d'une matrice de réparation d'adn donneur ayant des séquences répétées en tandem
US20230287370A1 (en) Novel cas enzymes and methods of profiling specificity and activity
KR20180074610A (ko) 동물 배아의 염기 교정용 조성물 및 염기 교정 방법
CN111902541A (zh) 增加细胞中感兴趣的核酸分子表达水平的方法
WO2018164457A1 (fr) Composition contenant une endonucléase c2cl pour étalonnage diélectrique, et procédé d'étalonnage diélectrique utilisant celle-ci
CN115772523A (zh) 一种碱基编辑工具
CN115968301A (zh) 优化的蛋白融合和接头
CA3155960A1 (fr) Vecteur d'administration d'acide nucleique comprenant un polynucleotide monocatenaire circulaire
CN114410625B (zh) 通过Cas9-crRNA复合物的RNA指导的DNA裂解
WO2024089629A1 (fr) Protéine cas12, système crispr-cas et leurs utilisations
KR20220039564A (ko) 신규의 개량된 염기 편집 또는 교정용 융합단백질 및 이의 용도
KR20180003366A (ko) Dna를 가이드로 한 엔도뉴클라아제의 제조방법 및 그 방법으로 제조된 엔도뉴클라아제
IL232832A (en) Methods and compositions for altering nucleic acid sequence are known in advance
CN114410625A (zh) 通过Cas9-crRNA复合物的RNA指导的DNA裂解

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16871007

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16871007

Country of ref document: EP

Kind code of ref document: A1